price objective on teva
ValuEngine raised Teva Pharmaceutical Industries from a âholdâ rating to a âbuyâ rating in a research note on Monday, October 2nd. Evercore ISI set a $38.00 price objective on Teva Pharmaceutical Industries and gave the company a âbuyâ rating in a research note on Wednesday, October 25th. Finally, Goldman Sachs Group raised Teva Pharmaceutical Industries from a âneutralâ rating to a âbuyâ rating and set a $20.00 price objective for the company in a research note on Friday, December 15th.